# A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma.

> **NCT07734116** · PHASE1,PHASE2 · RECRUITING · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 50 (estimated)

## Conditions studied

- Pediatric Malignant Solid Tumor and Epithelioid Sarcoma

## Interventions

- **DRUG:** ONO-4538HSC

## Key facts

- **NCT ID:** NCT07734116
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-15
- **Primary completion:** 2029-11-30
- **Final completion:** 2032-02-29
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07734116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07734116, "A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07734116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*